Atlas Trials

Gastric Adenocarcinoma and Gastroesophageal Junction Adenocarcinoma

5 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Gastric Adenocarcinoma and Gastroesophageal Junction Adenocarcinoma

RecordFirmDate
Retlirafusp Alfa Injection Plus Chemotherapy Versus Investigator's Choice of Anti-PD-1 Antibody Plus Chemotherapy as First-line Treatment for Advanced Gastric Cancer With Liver Metastases (NCT07677293)Peking University2026-06-26
SHR-1701 Combined With Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma With Peritoneal Metastasis (NCT07384234)Ruijin Hospital2026-04-24
Phase II RAINSPOT: Zolbetuximab-Paclitaxel-Ramucirumab for CLDN18.2 Positive Gastro-esophageal Cancer (NCT06962137)Universitaire Ziekenhuizen KU Leuven2025-12-11
AUGMENTED RESPONSE OF VOLATILE BIOMARKERS IN THE ASSESSMENT OF OESOPHAGOGASTRIC CANCER (AROMA2) (NCT07260734)Imperial College London2025-12-01
A Study of AK109 and AK104 in Advanced Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma (NCT04982276)Akeso2021-08-23

Track Gastric Adenocarcinoma and Gastroesophageal Junction Adenocarcinoma automatically

Every clearance here is in the API, with alerts when new ones post.